ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5,1,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,2,Headache,Headaches NEC,Headaches,Nerv,N
5,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
6,2,Adjusted calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
6,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,4,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
6,5,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
6,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
6,7,Blood fibrinogen increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
6,8,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
6,9,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
6,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6,12,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
6,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6,14,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
6,15,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
6,16,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
6,17,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
7,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
9,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
11,1,Electrocardiogram QT interval abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
12,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
12,2,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
12,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
13,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
14,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
15,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
15,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
16,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
17,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
18,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
18,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
18,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
20,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
22,1,Alanine aminotransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
22,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
22,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
23,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
23,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
24,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
25,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
26,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
27,1,Electrocardiogram T wave amplitude decreased,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
28,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
28,2,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
28,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
28,4,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
28,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
28,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
28,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
28,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
29,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
29,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
30,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
30,2,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
30,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
30,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
30,5,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
30,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
30,7,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
30,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
30,9,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
30,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
30,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
30,12,Osteosclerosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
30,13,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
31,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
31,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
31,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
31,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
31,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
31,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,7,Eosinophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
31,8,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
31,9,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
31,10,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
31,11,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
31,12,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,13,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
31,14,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
31,15,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
31,16,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
31,17,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
31,18,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
31,19,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
31,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,21,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,22,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
31,23,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
31,24,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
31,25,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
31,26,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
31,27,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
31,28,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
31,29,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,30,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
32,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
32,2,BRCA1 gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
32,3,Enterobacter bacteraemia,Enterobacter infections,Bacterial infectious disorders,Infec,N
32,4,Invasive lobular breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
32,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
32,6,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
33,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
33,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
33,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
34,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
34,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
34,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
34,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
35,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
35,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
36,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
37,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
38,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
38,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
39,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
39,2,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
39,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
39,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
40,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
41,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
41,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
41,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
41,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
41,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
41,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
42,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
43,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
44,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
45,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
45,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
45,3,Postoperative adhesion,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
46,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
46,2,Axillary mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
46,3,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
46,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
46,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
46,6,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
46,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
46,8,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
46,9,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
46,10,Job dissatisfaction,Employment issues,Economic and housing issues,SocCi,N
46,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
46,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
46,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
47,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
47,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
47,3,Lymphangiosis carcinomatosa,Metastases to specified sites,Metastases,Neopl,N
47,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
47,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
47,6,Osteosclerosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
47,7,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,8,Tumour marker increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
48,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
48,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
49,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
49,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
50,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
50,2,CYP3A4 polymorphism,Genetic polymorphisms,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
50,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
50,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
50,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
50,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
50,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
50,8,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
50,9,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
50,10,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
50,11,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
50,12,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
50,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
50,15,Pleural disorder,Pleural conditions NEC,Pleural disorders,Resp,N
50,16,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
50,17,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
51,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
51,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
52,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
53,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
53,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
53,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
53,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
53,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
54,1,Headache,Headaches NEC,Headaches,Nerv,N
54,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
55,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
55,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
55,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
56,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
56,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
56,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
56,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
56,5,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
56,6,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
56,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
56,8,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
56,9,Vulval abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
57,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
57,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
57,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
58,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
59,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
59,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
59,3,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
60,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
60,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
60,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
60,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
60,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
61,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
61,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
62,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
63,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
63,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
63,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
63,4,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
63,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Biopsy breast,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
64,2,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
64,3,Carbohydrate antigen 15-3 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
64,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
64,5,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
64,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
64,7,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
64,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
65,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
66,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
66,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
66,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
68,1,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
68,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
68,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
68,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
68,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
68,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
68,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,8,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
69,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
69,3,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
70,1,Cancer fatigue,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
71,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
71,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
71,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
71,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
72,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
72,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
72,4,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
72,5,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
73,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
73,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
73,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
73,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
73,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
73,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
73,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
73,8,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
74,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
75,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
76,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
77,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
78,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
78,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
78,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
79,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
80,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,Y
81,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
81,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
81,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
81,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
82,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
82,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
82,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
82,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
82,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
83,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
83,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
84,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
85,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
85,2,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
85,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
85,4,PIK3CA-activated mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
86,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
87,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
89,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
90,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
90,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
91,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
92,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
93,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
94,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
94,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
94,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
95,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
96,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
97,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
98,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
99,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
99,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
100,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
101,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
102,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
102,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
103,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
104,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
104,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
105,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
105,2,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
105,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
106,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
107,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
107,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
107,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
107,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
108,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
109,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
109,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
110,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
110,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,3,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
110,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
110,7,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
110,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
110,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
110,10,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
110,11,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
110,12,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
110,13,Mucosal toxicity,Mucosal findings abnormal,General system disorders NEC,Genrl,N
110,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
110,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,16,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
111,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
111,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
111,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
111,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
112,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
112,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
112,3,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
113,1,Alanine aminotransferase,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
113,2,Aspartate aminotransferase,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
114,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
115,1,Mesenteric artery thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
116,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
116,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
117,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
118,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
119,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
120,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
121,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
121,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
121,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
121,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
121,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
121,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
122,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
122,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
124,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
125,1,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
125,2,Mesenteric artery thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
126,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
127,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
128,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
128,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
131,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
132,2,Myocardial injury,Myocardial disorders NEC,Myocardial disorders,Card,Y
132,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
133,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
133,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
133,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
134,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
135,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
136,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
137,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
138,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
138,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
139,1,Carbohydrate antigen 15-3 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
139,2,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
139,3,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
139,4,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
140,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
141,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
142,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
142,2,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
143,1,Haptoglobin decreased,Haem metabolism analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
144,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
145,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
146,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
146,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
147,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
147,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
147,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
147,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
147,5,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
147,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
147,7,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
147,8,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
147,9,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
147,10,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
147,11,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
147,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
147,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
148,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
149,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
149,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
149,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
150,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
151,1,Alanine aminotransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
151,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
152,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
152,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
152,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
152,4,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
153,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
153,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
153,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
154,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
155,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
156,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
157,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
157,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
157,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
158,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
159,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
160,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
161,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
162,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
163,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
163,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
164,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
164,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
165,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
165,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
165,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
166,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
167,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
168,1,Breast calcifications,Breast disorders NEC,Breast disorders,Repro,N
169,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
170,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
171,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
172,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
173,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
174,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
175,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
176,1,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
177,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
177,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
177,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
177,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
177,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
177,6,Osteosclerosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
177,7,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
178,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
178,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
179,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
180,1,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
181,1,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
182,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
183,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
183,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
184,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
184,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
185,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
186,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
186,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
187,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
188,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
188,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
188,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
189,1,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
190,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
191,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
191,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
191,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
192,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
193,1,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
194,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
195,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
196,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
196,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
197,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
197,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
197,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
198,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
198,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
199,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
200,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
201,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
201,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
202,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
202,2,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
202,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
203,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
203,2,Myofascial pain syndrome,Muscle pains,Muscle disorders,Musc,N
204,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
204,2,Myofascial pain syndrome,Muscle pains,Muscle disorders,Musc,N
205,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
206,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
206,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
207,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
207,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
208,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
208,2,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
208,3,Myofascial pain syndrome,Muscle pains,Muscle disorders,Musc,N
208,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
209,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
210,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,2,Electrocardiogram QT shortened,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
210,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
211,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
211,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
212,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
212,2,Electrocardiogram QT interval,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
212,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
212,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
213,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
213,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
214,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
215,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
215,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
216,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
216,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
216,3,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
217,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
218,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
218,2,Myofascial pain syndrome,Muscle pains,Muscle disorders,Musc,N
219,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
220,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
221,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
221,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
221,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
222,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
223,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
224,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
225,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
225,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
226,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
227,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
227,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
227,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
227,4,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
227,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
227,6,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
227,7,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
227,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
228,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
229,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
229,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
229,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
230,1,Gene mutation identification test positive,Gene analyses,Cytogenetic investigations and genetic analyses,Inv,N
230,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
231,1,Blood bilirubin abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
232,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
232,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
232,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
233,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
234,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
234,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
234,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
235,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
236,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
236,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
236,3,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
236,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
236,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
236,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
236,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
237,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
237,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
238,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
238,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
238,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
239,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
240,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
241,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
